Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 205M | 225M | 217M | 201M | 203M | 196M |
| Cost of revenue | 28M | 32M | 35M | 31M | 32M | 30M |
| Gross profit | 177M | 193M | 182M | 171M | 171M | 166M |
| Research and development | 26M | 24M | 26M | 28M | 26M | 29M |
| Selling, general and administrative | 152M | 159M | 160M | 144M | 130M | 132M |
| Operating expenses | — | — | — | — | 156M | 161M |
| Operating income | −1M | 10M | −3M | −1M | 14M | 5M |
| Pre-tax income | 2M | 14M | −2M | 4M | 20M | 11M |
| Income tax | 14M | 4M | 1M | 1M | 2M | 1M |
| Net income | −11M | 10M | −4M | 3M | 18M | 10M |
| Earnings per share | −0.39 | 0.34 | −0.12 | 0.10 | 0.62 | 0.33 |
| Earnings per share, diluted | −0.39 | 0.34 | −0.12 | 0.10 | 0.60 | 0.32 |
| Weighted average shares | 29M | 29M | 30M | 30M | 30M | 30M |
| Weighted average shares, diluted | 29M | 30M | 30M | 30M | 31M | 30M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 99M | 105M | 113M | 107M | 54M | 150M | 148M | 188M |
| Short-term investments | 185M | 203M | 210M | 194M | 315M | 295M | 263M | 252M |
| Receivables | 105M | 120M | 108M | 138M | 93M | 93M | 90M | 80M |
| Inventory | 166M | 145M | 142M | 122M | 100M | 80M | 67M | 59M |
| Current assets | 567M | 584M | 586M | 573M | 572M | 631M | 583M | 607M |
| Property, plant and equipment | 101M | 98M | 92M | 85M | 77M | 72M | 67M | 62M |
| Total assets | 911M | 907M | 808M | 802M | 731M | 808M | 796M | 728M |
| Current liabilities | 89M | 96M | 111M | 93M | 63M | 89M | 74M | 66M |
| Total liabilities | 119M | 126M | 141M | 124M | 95M | 119M | 100M | 90M |
| Equity | 792M | 781M | 666M | 678M | 636M | 690M | 697M | 638M |
| Shares outstanding | 29M | 29M | 29M | 30M | 29M | 30M | 30M | 30M |
| Shares issued | 29M | 29M | 29M | 30M | 29M | 30M | 30M | 30M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 13M | — | — | −7M | — | — |
| Depreciation and amortisation | 5M | — | — | 3M | — | — |
| Share-based compensation | 31M | 30M | 42M | 31M | 28M | 32M |
| Capital expenditure | 10M | — | — | 8M | — | — |
| Investing cash flow | −11M | — | — | −2M | — | — |
| Share buybacks | 0 | — | — | 75M | — | — |
| Financing cash flow | −7M | — | — | −88M | — | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator